Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
TFEB-mediated lysosomal exocytosis alleviates high-fat diet–induced lipotoxicity in the kidney
Jun Nakamura, Takeshi Yamamoto, Yoshitsugu Takabatake, Tomoko Namba-Hamano, Satoshi Minami, Atsushi Takahashi, Jun Matsuda, Shinsuke Sakai, Hiroaki Yonishi, Shihomi Maeda, Sho Matsui, Isao Matsui, Takayuki Hamano, Masatomo Takahashi, Maiko Goto, Yoshihiro Izumi, Takeshi Bamba, Miwa Sasai, Masahiro Yamamoto, Taiji Matsusaka, Fumio Niimura, Motoko Yanagita, Shuhei Nakamura, Tamotsu Yoshimori, Andrea Ballabio, Yoshitaka Isaka
Jun Nakamura, Takeshi Yamamoto, Yoshitsugu Takabatake, Tomoko Namba-Hamano, Satoshi Minami, Atsushi Takahashi, Jun Matsuda, Shinsuke Sakai, Hiroaki Yonishi, Shihomi Maeda, Sho Matsui, Isao Matsui, Takayuki Hamano, Masatomo Takahashi, Maiko Goto, Yoshihiro Izumi, Takeshi Bamba, Miwa Sasai, Masahiro Yamamoto, Taiji Matsusaka, Fumio Niimura, Motoko Yanagita, Shuhei Nakamura, Tamotsu Yoshimori, Andrea Ballabio, Yoshitaka Isaka
View: Text | PDF
Research Article Metabolism Nephrology

TFEB-mediated lysosomal exocytosis alleviates high-fat diet–induced lipotoxicity in the kidney

  • Text
  • PDF
Abstract

Obesity is a major risk factor for end-stage kidney disease. We previously found that lysosomal dysfunction and impaired autophagic flux contribute to lipotoxicity in obesity-related kidney disease, in both humans and experimental animal models. However, the regulatory factors involved in countering renal lipotoxicity are largely unknown. Here, we found that palmitic acid strongly promoted dephosphorylation and nuclear translocation of transcription factor EB (TFEB) by inhibiting the mechanistic target of rapamycin kinase complex 1 pathway in a Rag GTPase–dependent manner, though these effects gradually diminished after extended treatment. We then investigated the role of TFEB in the pathogenesis of obesity-related kidney disease. Proximal tubular epithelial cell–specific (PTEC-specific) Tfeb-deficient mice fed a high-fat diet (HFD) exhibited greater phospholipid accumulation in enlarged lysosomes, which manifested as multilamellar bodies (MLBs). Activated TFEB mediated lysosomal exocytosis of phospholipids, which helped reduce MLB accumulation in PTECs. Furthermore, HFD-fed, PTEC-specific Tfeb-deficient mice showed autophagic stagnation and exacerbated injury upon renal ischemia/reperfusion. Finally, higher body mass index was associated with increased vacuolation and decreased nuclear TFEB in the proximal tubules of patients with chronic kidney disease. These results indicate a critical role of TFEB-mediated lysosomal exocytosis in counteracting renal lipotoxicity.

Authors

Jun Nakamura, Takeshi Yamamoto, Yoshitsugu Takabatake, Tomoko Namba-Hamano, Satoshi Minami, Atsushi Takahashi, Jun Matsuda, Shinsuke Sakai, Hiroaki Yonishi, Shihomi Maeda, Sho Matsui, Isao Matsui, Takayuki Hamano, Masatomo Takahashi, Maiko Goto, Yoshihiro Izumi, Takeshi Bamba, Miwa Sasai, Masahiro Yamamoto, Taiji Matsusaka, Fumio Niimura, Motoko Yanagita, Shuhei Nakamura, Tamotsu Yoshimori, Andrea Ballabio, Yoshitaka Isaka

×

Figure 3

TFEB alleviates phospholipid accumulation in enlarged lysosomes during lipid overload in PTECs.

Options: View larger image (or click on image) Download as PowerPoint
TFEB alleviates phospholipid accumulation in enlarged lysosomes during l...
(A) Immunofluorescence images of LAMP1 after BSA or PA treatment for 24 hours (n = 3). (B–F) To investigate the role of TFEB in the kidneys under lipid overload, 8-week-old Tfebfl/fl KAP and Tfebfl/fl control mice were fed an ND or HFD for 2 months. (B) Immunostaining images showing TFEB in the kidney cortical regions (n = 6–7). The percentage of PTECs exhibiting TFEB nuclear translocation was determined. (C) Western blot images of TFEB in nuclear and cytosolic fractions of kidneys (n = 6–7). TFEB nuclear/cytosolic ratios are shown. Nuclear and cytosolic TFEB levels were normalized for Lamin A/C and GAPDH levels, respectively. (D and E) Images of PAS staining, LAMP1 immunostaining, toluidine blue staining (D), and Nile red staining (E) in the kidney cortical regions (n = 5–6). Sections were immunostained for LRP2, a marker of proximal tubules (blue) (D) and counterstained with hematoxylin (bluish purple) (D) and DAPI (E). (D) Vacuole scores are shown. (E) The number (per proximal tubule) of Nile red–positive dots was counted. (E) Images of electron micrographs of the kidneys. The number of MLBs was counted (n = 3). Bars: 10 μm (A), 40 μm (B and E), 50 μm (D), and 5 μm (F). Values represent means ± SEM. Statistically significant differences: *P < 0.05 versus treatment-matched Tfebfl/fl control littermates or wild-type PTECs; #P < 0.05 versus nonobese mice or BSA-treated PTECs (A, 1-way ANOVA followed by Dunnett’s test; D–F, 1-way ANOVA followed by Tukey-Kramer test; B and C, 2-tailed Student’s t test). All images are representative of multiple experiments. WT, wild-type PTECs; KO, Tfeb-deficient PTECs; OE, Tfeb-overexpressing PTECs; BM, basement membrane; MLB, multilamellar body; TL, tubular lumen; N, nucleus; F/F, Tfebfl/fl mice; F/F;KAP, Tfebfl/fl KAP mice; PAS, periodic acid–Schiff; TB, toluidine blue.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts